Agah Ramtin — SEC Form 4 filings
SEC reporting owner CIK 1862617. 17 Form 4 filings on record with FilingPulse; latest filed 2026-04-07.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-01-23 to 2026-04-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 13 legs across 12 filings — 216,983 shares, $161,107 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: purchase of 21,000 shares @ $1.40 ($29,400) in RenovoRx, Inc., filed 2025-06-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RenovoRx, Inc. (RNXT) | Chief Medical Officer, Director | 17 | 13 legs · 216,983 sh · $161,107 | — | 7 |
Form 4 filings — Agah Ramtin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-07 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 621,727 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 10,000 @ $1.00 | EDGAR |
| 2026-01-05 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 9,795 @ $0.86 | EDGAR |
| 2026-01-02 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 205 @ $0.83 | EDGAR |
| 2025-12-17 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 12,000 @ $0.85 | EDGAR |
| 2025-12-08 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 10,000 @ $0.96 | EDGAR |
| 2025-11-24 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 10,000 @ $0.80 · Purchase (P): 12,000 @ $0.80 | EDGAR |
| 2025-07-03 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 63,636 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 21,000 @ $1.40 | EDGAR |
| 2025-06-06 | 4 | RenovoRx, Inc. (RNXT) | Gift (G): 400,000 @ $0 | EDGAR |
| 2025-04-17 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 15,000 @ $0.90 | EDGAR |
| 2025-04-16 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 254,542 (derivative) @ $0 | EDGAR |
| 2025-04-14 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 20,000 @ $0.80 | EDGAR |
| 2025-04-10 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 30,000 @ $0.81 | EDGAR |
| 2025-04-09 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 26,000 @ $0.84 | EDGAR |
| 2024-01-30 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 40,983 · Purchase (P): 40,983 (derivative) | EDGAR |
| 2024-01-23 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 28,424 (derivative) @ $0 · Grant/award (A): 125,132 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1862617 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →